BioStem Technologies (BSEM) director Jodi Ungrodt reports common stock and RSU positions
Rhea-AI Filing Summary
BioStem Technologies, Inc. director Jodi Ungrodt reported initial beneficial ownership on a Form 3. The filing lists 5,647 Restricted Stock Units, each representing a contingent right to receive one share of common stock, and 5,648 shares of common stock, all held directly. The RSUs vest in two installments, with one tranche vesting on May 27, 2026 and the remaining tranche vesting on August 27, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
UNGRODT JODI
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Units F2, F1 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 5,647 shares (Direct);
Common Stock — 5,648 shares (Direct)
Footnotes (2)
- F1. These restricted stock units vest in two installments. The first installment vested on May 27, 2026 and the remaining installment vests on August 27, 2026.
- F2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Key Figures
Restricted Stock Units: 5,647 units
Common stock held: 5,648 shares
RSU first vesting date: May 27, 2026
+1 more
4 metrics
Restricted Stock Units
5,647 units
RSUs held by Jodi Ungrodt, each convertible into one share of common stock
Common stock held
5,648 shares
Direct common stock holdings following the reported date
RSU first vesting date
May 27, 2026
First installment of RSUs vested on this date
RSU final vesting date
August 27, 2026
Remaining RSU installment vests on this date
Key Terms
Restricted Stock Units, contingent right, beneficial ownership
3 terms
Restricted Stock Units financial
"These restricted stock units vest in two installments."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
beneficial ownership financial
"director Jodi Ungrodt reported initial beneficial ownership on a Form 3"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What did BioStem Technologies (BSEM) disclose in this Form 3 for Jodi Ungrodt?
The Form 3 shows that director Jodi Ungrodt initially reported holdings of 5,647 Restricted Stock Units and 5,648 shares of common stock, all held directly as of the reported date.
How many Restricted Stock Units does Jodi Ungrodt hold in BSEM?
Jodi Ungrodt holds 5,647 Restricted Stock Units, each representing a contingent right to receive one share of BioStem Technologies common stock. These RSUs are reported as a direct derivative position in the filing.
What is the vesting schedule of Jodi Ungrodt’s BSEM Restricted Stock Units?
The 5,647 Restricted Stock Units vest in two installments. The first installment vested on May 27, 2026, and the remaining installment is scheduled to vest on August 27, 2026, according to the footnotes.
What does each Restricted Stock Unit represent for BSEM’s Jodi Ungrodt?
Each of Jodi Ungrodt’s Restricted Stock Units represents a contingent right to receive one share of BioStem Technologies common stock, as described in the footnotes to the Form 3.
AI-generated analysis. How Rhea-AI works. Not financial advice.
